Loeys T, Goetghebeur E
Clinical Biostatistics, Merck Sharp & Dohme (Europe), Clos du Lynx 5, 1200 Woluwe, Belgium.
Biometrics. 2003 Mar;59(1):100-5. doi: 10.1111/1541-0420.00012.
Survival data from randomized trials are most often analyzed in a proportional hazards (PH) framework that follows the intention-to-treat (ITT) principle. When not all the patients on the experimental arm actually receive the assigned treatment, the ITT-estimator mixes its effect on treatment compliers with its absence of effect on noncompliers. The structural accelerated failure time (SAFT) models of Robins and Tsiatis are designed to consistently estimate causal effects on the treated, without direct assumptions about the compliance selection mechanism. The traditional PH-model, however, has not yet led to such causal interpretation. In this article, we examine a PH-model of treatment effect on the treated subgroup. While potential treatment compliance is unobserved in the control arm, we derive an estimating equation for the Compliers PROPortional Hazards Effect of Treatment (C-PROPHET). The jackknife is used for bias correction and variance estimation. The method is applied to data from a recently finished clinical trial in cancer patients with liver metastases.
来自随机试验的生存数据通常在遵循意向性治疗(ITT)原则的比例风险(PH)框架内进行分析。当试验组中并非所有患者都实际接受了分配的治疗时,ITT估计器将其对治疗依从者的影响与对不依从者无影响这一情况混合在一起。罗宾斯(Robins)和齐亚蒂斯(Tsiatis)的结构加速失效时间(SAFT)模型旨在一致地估计对接受治疗者的因果效应,而无需对依从性选择机制做出直接假设。然而,传统的PH模型尚未得出这样的因果解释。在本文中,我们研究了对接受治疗亚组的治疗效果的PH模型。虽然在对照组中潜在的治疗依从性未被观察到,但我们推导了治疗的依从者比例风险效应(C-PROPHET)的估计方程。采用刀切法进行偏差校正和方差估计。该方法应用于来自最近完成的一项针对肝转移癌患者的临床试验的数据。